Shagun Singh
Stock Analyst at RBC Capital
(2.52)
# 2,394
Out of 5,030 analysts
230
Total ratings
50%
Success rate
-0.72%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Reiterates: Sector Perform | $211 | $188.49 | +11.94% | 2 | Oct 16, 2025 | |
| ABT Abbott Laboratories | Reiterates: Outperform | $147 | $128.28 | +14.59% | 17 | Oct 16, 2025 | |
| BSX Boston Scientific | Reiterates: Outperform | $125 | $99.08 | +26.17% | 17 | Sep 29, 2025 | |
| OM Outset Medical | Reiterates: Sector Perform | $22 | $13.16 | +67.17% | 13 | Aug 19, 2025 | |
| ISRG Intuitive Surgical | Reiterates: Outperform | $615 | $444.24 | +38.44% | 16 | Aug 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $112 → $115 | $101.15 | +13.69% | 16 | Aug 8, 2025 | |
| PODD Insulet | Maintains: Outperform | $330 → $350 | $319.37 | +9.59% | 2 | Aug 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Outperform | $45 → $25 | $14.67 | +70.42% | 3 | Aug 7, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $215 → $180 | $77.78 | +131.42% | 6 | Aug 5, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $130 → $135 | $127.63 | +5.77% | 22 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $330 → $325 | $251.36 | +29.30% | 15 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $89 | $74.17 | +19.99% | 22 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $185 | $192.63 | -3.96% | 22 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $1.30 | +130.77% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $105 → $101 | $95.19 | +6.10% | 21 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $372.95 | +16.64% | 19 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $92 | $59.33 | +55.06% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $115 | $66.23 | +73.64% | 4 | Oct 25, 2024 |
Becton, Dickinson and Company
Oct 16, 2025
Reiterates: Sector Perform
Price Target: $211
Current: $188.49
Upside: +11.94%
Abbott Laboratories
Oct 16, 2025
Reiterates: Outperform
Price Target: $147
Current: $128.28
Upside: +14.59%
Boston Scientific
Sep 29, 2025
Reiterates: Outperform
Price Target: $125
Current: $99.08
Upside: +26.17%
Outset Medical
Aug 19, 2025
Reiterates: Sector Perform
Price Target: $22
Current: $13.16
Upside: +67.17%
Intuitive Surgical
Aug 19, 2025
Reiterates: Outperform
Price Target: $615
Current: $444.24
Upside: +38.44%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $112 → $115
Current: $101.15
Upside: +13.69%
Insulet
Aug 8, 2025
Maintains: Outperform
Price Target: $330 → $350
Current: $319.37
Upside: +9.59%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $14.67
Upside: +70.42%
Inspire Medical Systems
Aug 5, 2025
Maintains: Outperform
Price Target: $215 → $180
Current: $77.78
Upside: +131.42%
Teleflex
Aug 1, 2025
Maintains: Sector Perform
Price Target: $130 → $135
Current: $127.63
Upside: +5.77%
Jul 30, 2025
Maintains: Outperform
Price Target: $330 → $325
Current: $251.36
Upside: +29.30%
Jul 25, 2025
Maintains: Outperform
Price Target: $85 → $89
Current: $74.17
Upside: +19.99%
Jul 17, 2025
Maintains: Outperform
Price Target: $181 → $185
Current: $192.63
Upside: -3.96%
Jul 15, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $1.30
Upside: +130.77%
May 22, 2025
Maintains: Outperform
Price Target: $105 → $101
Current: $95.19
Upside: +6.10%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $372.95
Upside: +16.64%
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $59.33
Upside: +55.06%
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $66.23
Upside: +73.64%